.jpg "Phát hiện điểm bất thường dưới đáy Ấn Độ Dương, có thể là vị trí máy bay MH370 rơi")
.jpg "Kim Thanh reclaims more than 234 hectares of land to build an industrial park")
.jpg "Binh Giang's first quarter budget revenue reached nearly half of the province's annual target.")
.jpg "Early spring tea")
Submit a comment
Indian police have arrested three employees of Marion Biotech and are searching for two of its directors, after government tests revealed that more than 20 samples of syrup were adulterated and counterfeit.
Police investigate the office of biotechnology company Marion Biotech on the outskirts of New Delhi (India)
On March 4, Indian officials said the country may issue a warning on cough syrup exports by Marion Biotech, after test results showed that many samples of the company's medicine contained substances harmful to health.
Indian police on March 3 arrested three employees of Marion and searched for two directors of the company, after tests at a government laboratory showed that 22 out of 36 syrup samples were adulterated and counterfeit.
Marion case investigator Vaibhav Babbar said the syrups contained ethylene glycol and diethylene glycol, two compounds used as antifreeze in industrial products.
He stressed that Marion's drugs had been exported to many countries and that the Indian Ministry of Health might issue a warning about the use of the product. These drugs have also been exported to Kyrgyzstan and Cambodia.
Mr. Babbar had previously inspected Marion's factory four times after Uzbekistan reported in December 2022 that a child had died from drinking the company's cough syrup.
Analysis by the Ministry of Health of Uzbekistan showed that Ambronol and DOK-1 Max syrups both contained large amounts of diethylene glycol or ethylene glycol. Children were given these drugs in higher doses than the standard dose either because their parents mistook the products for cold medicine or on the advice of pharmacists.
More than 300 children, mostly under the age of five, died last year from acute kidney injury linked to cough syrups from different manufacturers in Gambia, Indonesia and Uzbekistan, according to a report released by the World Health Organization (WHO) in January.
The Philippines, Timor Leste, Senegal and Cambodia are also at risk because the drug is still being sold, so the WHO is calling on member states to take urgent action to prevent further deaths.
DOK-1 Max Syrup is manufactured by Indian pharmaceutical company Marion Biotech Pvt Ltd.
According to Vietnam+
.jpg "Hai Duong's agricultural, forestry and fishery value increased by 7.51% in the first quarter.")
